ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 (2021)
Leão, Matheus de Castro; Pohlmann, Adriana Raffin ; Farsky, Sandra Helena Poliselli ; Broering, Milena Fronza; Castro, Inar Alves de ; Guterres, Sílvia Stanisçuaski
Source: Atherosclerosis. Conference titles: Congress European Atherosclerosis Society/EAS. Unidade: FCF
Subjects: ARTERIOSCLEROSE, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEÃO, Matheus de Castro et al. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf? Acesso em: 04 out. 2023. , 2021
APA
Leão, M. de C., Pohlmann, A. R., Farsky, S. H. P., Broering, M. F., Castro, I. A. de, & Guterres, S. S. (2021). Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
NLM
Leão M de C, Pohlmann AR, Farsky SHP, Broering MF, Castro IA de, Guterres SS. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 [Internet]. Atherosclerosis. 2021 ; 331 e73 res. P053.[citado 2023 out. 04 ] Available from: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
Vancouver
Leão M de C, Pohlmann AR, Farsky SHP, Broering MF, Castro IA de, Guterres SS. Toxicity evaluation of docosahexaenoic acid nanoencapsulated with anti-PECAM-1 [Internet]. Atherosclerosis. 2021 ; 331 e73 res. P053.[citado 2023 out. 04 ] Available from: https://pdf.sciencedirectassets.com/271064/1-s2.0-S0021915021X00147/1-s2.0-S0021915021004846/main.pdf?
Trabalho de evento-resumo periodico
Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans (2021)
Santana, Tamires Miranda ; Ogawa, Lucas Yuiiti; Rogero, Marcelo Macedo ; Barroso, Lucia Pereira; Castro, Inar Alves de
Source: Atherosclerosis. Conference titles: Congress European Atherosclerosis Society/EAS. Unidades: FSP, IME, FCF
Subjects: BIOMARCADORES, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Tamires Miranda et al. Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans. Atherosclerosis. Clare: Faculdade de Saúde Pública, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2021.06.768. Acesso em: 04 out. 2023. , 2021
APA
Santana, T. M., Ogawa, L. Y., Rogero, M. M., Barroso, L. P., & Castro, I. A. de. (2021). Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans. Atherosclerosis. Clare: Faculdade de Saúde Pública, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2021.06.768
NLM
Santana TM, Ogawa LY, Rogero MM, Barroso LP, Castro IA de. Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans [Internet]. Atherosclerosis. 2021 ; 331 e251 res. P609.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.06.768
Vancouver
Santana TM, Ogawa LY, Rogero MM, Barroso LP, Castro IA de. Effect of supplementation with resveratrol on biomarkers associated with atherosclerosis in humans [Internet]. Atherosclerosis. 2021 ; 331 e251 res. P609.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.06.768
Artigo de periodico
Aerobic exercise training reduces insulin resistance and atherogenesis induced by low-sodium diet in LDL receptor knockout mice (2021)
Bochi, Ana Paula Garcia ; Ferreira, Guilherme da Silva ; Pinto, Paula Ramos ; Bianco, Vanessa Del; Rodrigues, Letícia Gomes ; Trevisani, M. S.; Bispo, K. C. S.; Capelozzi, Vera Luiza ; Nakandakare, Edna Regina ; Machado, Ubiratan Fabres ; Teodoro, W. R.; Passarelli, Marisa ; Catanozi, Sergio
Source: Atherosclerosis. Unidades: FM, ICB
Subjects: FISIOLOGIA, TREINAMENTO AERÓBIO, RESISTÊNCIA À INSULINA, GORDURAS, DIETA ANIMAL, DIETA COM RESTRIÇÃO DE GORDURAS, SÓDIO, PRESSÃO SANGUÍNEA, CAMUNDONGOS, LIPÍDEOS, PRESSÃO SANGUÍNEA, ANGIOTENSINA II
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCHI, Ana Paula Garcia et al. Aerobic exercise training reduces insulin resistance and atherogenesis induced by low-sodium diet in LDL receptor knockout mice. Atherosclerosis, v. 331, p. e102-e103, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2021.06.302. Acesso em: 04 out. 2023.
APA
Bochi, A. P. G., Ferreira, G. da S., Pinto, P. R., Bianco, V. D., Rodrigues, L. G., Trevisani, M. S., et al. (2021). Aerobic exercise training reduces insulin resistance and atherogenesis induced by low-sodium diet in LDL receptor knockout mice. Atherosclerosis, 331, e102-e103. doi:10.1016/j.atherosclerosis.2021.06.302
NLM
Bochi APG, Ferreira G da S, Pinto PR, Bianco VD, Rodrigues LG, Trevisani MS, Bispo KCS, Capelozzi VL, Nakandakare ER, Machado UF, Teodoro WR, Passarelli M, Catanozi S. Aerobic exercise training reduces insulin resistance and atherogenesis induced by low-sodium diet in LDL receptor knockout mice [Internet]. Atherosclerosis. 2021 ; 331 e102-e103.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.06.302
Vancouver
Bochi APG, Ferreira G da S, Pinto PR, Bianco VD, Rodrigues LG, Trevisani MS, Bispo KCS, Capelozzi VL, Nakandakare ER, Machado UF, Teodoro WR, Passarelli M, Catanozi S. Aerobic exercise training reduces insulin resistance and atherogenesis induced by low-sodium diet in LDL receptor knockout mice [Internet]. Atherosclerosis. 2021 ; 331 e102-e103.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.06.302
Trabalho de evento-resumo periodico
Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? (2021)
Pimentel, Mariana Vieira de Mello Barros ; Barroso, Lucia Pereira; Castro, Inar Alves de
Source: Atherosclerosis. Conference titles: Congress European Atherosclerosis Society/EAS. Unidades: IME, FCF
Subjects: BIOMARCADORES, ESTRESSE OXIDATIVO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, Mariana Vieira de Mello Barros e BARROSO, Lucia Pereira e CASTRO, Inar Alves de. Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease?. Atherosclerosis. Clare: Instituto de Matemática e Estatística, Universidade de São Paulo. Disponível em: https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf. Acesso em: 04 out. 2023. , 2021
APA
Pimentel, M. V. de M. B., Barroso, L. P., & Castro, I. A. de. (2021). Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? Atherosclerosis. Clare: Instituto de Matemática e Estatística, Universidade de São Paulo. Recuperado de https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf
NLM
Pimentel MV de MB, Barroso LP, Castro IA de. Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? [Internet]. Atherosclerosis. 2021 ; 331 e210 res. P485.[citado 2023 out. 04 ] Available from: https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf
Vancouver
Pimentel MV de MB, Barroso LP, Castro IA de. Could oxidative stress biomarkers be applied to improve risk stratification of patients with cardiovascular disease? [Internet]. Atherosclerosis. 2021 ; 331 e210 res. P485.[citado 2023 out. 04 ] Available from: https://www.atherosclerosis-journal.com/article/S0021-9150(21)00916-3/pdf
Artigo de periodico
Perinatal exposure to maternal smoking and adulthood smoking behaviors in predicting cardiovascular diseases: A prospective cohort study (2021)
Qiying, Song; Qi, Lu; Sun, Dianjianyi; Zhou, Tao; Li, Xiang; Ma, Hao; Liang, Zhaoxia; Wang, Haijun; Cardoso, Marly Augusto ; Heianza, Yoriko
Source: Atherosclerosis. Unidade: FSP
Subjects: TABAGISMO, DOENÇAS CARDIOVASCULARES, SAÚDE MATERNO-INFANTIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QIYING, Song et al. Perinatal exposure to maternal smoking and adulthood smoking behaviors in predicting cardiovascular diseases: A prospective cohort study. Atherosclerosis, v. 328, p. 52-59, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2021.05.009. Acesso em: 04 out. 2023.
APA
Qiying, S., Qi, L., Sun, D., Zhou, T., Li, X., Ma, H., et al. (2021). Perinatal exposure to maternal smoking and adulthood smoking behaviors in predicting cardiovascular diseases: A prospective cohort study. Atherosclerosis, 328, 52-59. doi:10.1016/j.atherosclerosis.2021.05.009
NLM
Qiying S, Qi L, Sun D, Zhou T, Li X, Ma H, Liang Z, Wang H, Cardoso MA, Heianza Y. Perinatal exposure to maternal smoking and adulthood smoking behaviors in predicting cardiovascular diseases: A prospective cohort study [Internet]. Atherosclerosis. 2021 ;328 52-59.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.05.009
Vancouver
Qiying S, Qi L, Sun D, Zhou T, Li X, Ma H, Liang Z, Wang H, Cardoso MA, Heianza Y. Perinatal exposure to maternal smoking and adulthood smoking behaviors in predicting cardiovascular diseases: A prospective cohort study [Internet]. Atherosclerosis. 2021 ;328 52-59.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2021.05.009
Artigo de periodico
Familial hypercholesterolemia and cardiovascular disease in older individuals (2021)
Coutinho, Elaine R; Minami, Marcio H; Rocha, Viviane Z; Bittencourt, Márcio Sommer ; Jannes, Cinthia E; Tada, Mauricio T; Lima, Isabella R; Salgado Filho, Wilson; Chacra, Ana P; Pereira, Alexandre C; Krieger, Jose Eduardo ; Santos, Raul D
Source: Atherosclerosis. Unidades: HU, FM
Subjects: HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, IDOSOS, ENVELHECIMENTO, ARTERIOSCLEROSE, COLESTEROL, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COUTINHO, Elaine R et al. Familial hypercholesterolemia and cardiovascular disease in older individuals. Atherosclerosis, v. 318, p. 32-37, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.12.012. Acesso em: 04 out. 2023.
APA
Coutinho, E. R., Minami, M. H., Rocha, V. Z., Bittencourt, M. S., Jannes, C. E., Tada, M. T., et al. (2021). Familial hypercholesterolemia and cardiovascular disease in older individuals. Atherosclerosis, 318, 32-37. doi:10.1016/j.atherosclerosis.2020.12.012
NLM
Coutinho ER, Minami MH, Rocha VZ, Bittencourt MS, Jannes CE, Tada MT, Lima IR, Salgado Filho W, Chacra AP, Pereira AC, Krieger JE, Santos RD. Familial hypercholesterolemia and cardiovascular disease in older individuals [Internet]. Atherosclerosis. 2021 ; 318 32-37.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.12.012
Vancouver
Coutinho ER, Minami MH, Rocha VZ, Bittencourt MS, Jannes CE, Tada MT, Lima IR, Salgado Filho W, Chacra AP, Pereira AC, Krieger JE, Santos RD. Familial hypercholesterolemia and cardiovascular disease in older individuals [Internet]. Atherosclerosis. 2021 ; 318 32-37.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.12.012
Artigo de periodico
Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) (2020)
Cardoso, Rhanderson; Generoso, Giuliano; Staniak, Henrique L; Foppa, Murilo; Duncan, Bruce B; Pereira, Alexandre C; Blaha, Michael J; Blankstein, Ron; Benseñor, Isabela Judith Martins ; Lotufo, Paulo Andrade
Source: Atherosclerosis. Unidade: FM
Subjects: ESTUDOS LONGITUDINAIS, FATORES DE RISCO, CÁLCIO, VASOS CORONÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Rhanderson et al. Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis, v. 309, p. 8-15, 2020Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/38247. Acesso em: 04 out. 2023.
APA
Cardoso, R., Generoso, G., Staniak, H. L., Foppa, M., Duncan, B. B., Pereira, A. C., et al. (2020). Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis, 309, 8-15. doi:10.1016/j.atherosclerosis.2020.07.003
NLM
Cardoso R, Generoso G, Staniak HL, Foppa M, Duncan BB, Pereira AC, Blaha MJ, Blankstein R, Benseñor IJM, Lotufo PA. Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) [Internet]. Atherosclerosis. 2020 ; 309 8-15.[citado 2023 out. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/38247
Vancouver
Cardoso R, Generoso G, Staniak HL, Foppa M, Duncan BB, Pereira AC, Blaha MJ, Blankstein R, Benseñor IJM, Lotufo PA. Predictors of coronary artery calcium incidence and progression: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) [Internet]. Atherosclerosis. 2020 ; 309 8-15.[citado 2023 out. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/38247
Artigo de periodico
Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes (2020)
Ramin-mangata, Stephane; Wargny, Matthieu; Pichelin, Matthieu; May, Cedric Le; Thedrez, Aurelie; Blanchard, Valentin; Nativel, Brice; Santos, Raul D; Bensenor, Isabela Judith Martins ; Lotufo, Paulo Andrade
Source: Atherosclerosis. Unidade: FM
Subjects: LIPOPROTEÍNAS LDL, ENZIMAS PROTEOLÍTICAS, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, HOMEOSTASE, GLICOSE, FATORES DE RISCO, ELISA, ESTUDOS LONGITUDINAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMIN-MANGATA, Stephane et al. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. Atherosclerosis, v. 293, p. 49-56, 2020Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/35376. Acesso em: 04 out. 2023.
APA
Ramin-mangata, S., Wargny, M., Pichelin, M., May, C. L., Thedrez, A., Blanchard, V., et al. (2020). Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. Atherosclerosis, 293, 49-56. doi:10.1016/j.atherosclerosis.2019.11.027
NLM
Ramin-mangata S, Wargny M, Pichelin M, May CL, Thedrez A, Blanchard V, Nativel B, Santos RD, Bensenor IJM, Lotufo PA. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes [Internet]. Atherosclerosis. 2020 ; 293 49-56.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/35376
Vancouver
Ramin-mangata S, Wargny M, Pichelin M, May CL, Thedrez A, Blanchard V, Nativel B, Santos RD, Bensenor IJM, Lotufo PA. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes [Internet]. Atherosclerosis. 2020 ; 293 49-56.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/35376
Artigo de periodico
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels (2020)
Zheng, Kang H; Kaiser, Yannick; Olden, Casper C. van; Santos Filho, Raul Dias dos ; Dasseux, Jean-Louis; Genest, Jacques; Gaudet, Daniel; Westerink, Jan; Verberne, Hein J
Source: Atherosclerosis. Unidade: FM
Subjects: APOLIPOPROTEÍNAS, COLESTEROL, LIPOPROTEÍNAS HDL, MEIA IDADE, FOSFOLIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZHENG, Kang H et al. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, v. 311, p. 13-19, 2020Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/38277. Acesso em: 04 out. 2023.
APA
Zheng, K. H., Kaiser, Y., Olden, C. C. van, Santos Filho, R. D. dos, Dasseux, J. -L., Genest, J., et al. (2020). No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, 311, 13-19. doi:10.1016/j.atherosclerosis.2020.08.004
NLM
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2023 out. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/38277
Vancouver
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2023 out. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/38277
Artigo de periodico
Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study (2020)
Janovsky, Carolina Castro Porto Silva; Generoso, Giuliano; Goulart, Alessandra C; Santos Filho, Raul Dias dos ; Blaha, Michael J; Jones, Steven; Toth, Peter P.; Lotufo, Paulo Andrade ; Bittencourt, Marcio Sommer; Benseñor, Isabela Judith Martins
Source: Atherosclerosis. Unidade: FM
Subjects: COLESTEROL, HIPERTIREOIDISMO, DIAGNÓSTICO, EPIDEMIOLOGIA, MEIA IDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANOVSKY, Carolina Castro Porto Silva et al. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study. Atherosclerosis, v. 312, p. 60-65, 2020Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/38284. Acesso em: 04 out. 2023.
APA
Janovsky, C. C. P. S., Generoso, G., Goulart, A. C., Santos Filho, R. D. dos, Blaha, M. J., Jones, S., et al. (2020). Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study. Atherosclerosis, 312, 60-65. doi:10.1016/j.atherosclerosis.2020.08.021
NLM
Janovsky CCPS, Generoso G, Goulart AC, Santos Filho RD dos, Blaha MJ, Jones S, Toth PP, Lotufo PA, Bittencourt MS, Benseñor IJM. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study [Internet]. Atherosclerosis. 2020 ; 312 60-65.[citado 2023 out. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/38284
Vancouver
Janovsky CCPS, Generoso G, Goulart AC, Santos Filho RD dos, Blaha MJ, Jones S, Toth PP, Lotufo PA, Bittencourt MS, Benseñor IJM. Differences in HDL particle size in the presence of subclinical thyroid dysfunctions: the ELSA-Brasil study [Internet]. Atherosclerosis. 2020 ; 312 60-65.[citado 2023 out. 04 ] Available from: https://observatorio.fm.usp.br/handle/OPI/38284
Artigo de periodico-carta/editorial
Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? (2020)
Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: ARTERIOSCLEROSE, CALCIFICAÇÃO FISIOLÓGICA, VASOS CORONÁRIOS, CORONARIOPATIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels?. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://observatorio.fm.usp.br/handle/OPI/35425. Acesso em: 04 out. 2023. , 2020
APA
Santos Filho, R. D. dos. (2020). Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2019.12.019
NLM
Santos Filho RD dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? [Internet]. Atherosclerosis. 2020 ; 294 44-45.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/35425
Vancouver
Santos Filho RD dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? [Internet]. Atherosclerosis. 2020 ; 294 44-45.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/35425
Artigo de periodico-carta/editorial
Very high LDL cholesterol: the power of zero passes another test [Editorial] (2020)
Bittencourt, Márcio Sommer; Nasir, Khurram; Santos, Raul D; Al-Mallah, Mouaz H
Source: Atherosclerosis. Unidade: HU
Subjects: HIPERLIPIDEMIA, CÁLCIO, FATORES DE RISCO, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer et al. Very high LDL cholesterol: the power of zero passes another test [Editorial]. Atherosclerosis. Amsterdam: Hospital Universitário, Universidade de São Paulo. Disponível em: https://repositorio.usp.br/directbitstream/bf37607c-04fb-410f-bf80-1067a2b11369/2982139.pdf. Acesso em: 04 out. 2023. , 2020
APA
Bittencourt, M. S., Nasir, K., Santos, R. D., & Al-Mallah, M. H. (2020). Very high LDL cholesterol: the power of zero passes another test [Editorial]. Atherosclerosis. Amsterdam: Hospital Universitário, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2019.11.019
NLM
Bittencourt MS, Nasir K, Santos RD, Al-Mallah MH. Very high LDL cholesterol: the power of zero passes another test [Editorial] [Internet]. Atherosclerosis. 2020 ; 292 207-208.[citado 2023 out. 04 ] Available from: https://repositorio.usp.br/directbitstream/bf37607c-04fb-410f-bf80-1067a2b11369/2982139.pdf
Vancouver
Bittencourt MS, Nasir K, Santos RD, Al-Mallah MH. Very high LDL cholesterol: the power of zero passes another test [Editorial] [Internet]. Atherosclerosis. 2020 ; 292 207-208.[citado 2023 out. 04 ] Available from: https://repositorio.usp.br/directbitstream/bf37607c-04fb-410f-bf80-1067a2b11369/2982139.pdf
Artigo de periodico
Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil (2019)
Harada, Paulo H; Benseñor, Isabela M; Drager, Luciano F; Goulart, Alessandra Carvalho; Mill, José G; Lotufo, Paulo Andrade
Source: Atherosclerosis. Unidades: FM, HU
Subjects: FÍGADO GORDUROSO, AORTA, DOENÇAS CARDIOVASCULARES, OBESIDADE, GRUPOS ÉTNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARADA, Paulo H et al. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil. Atherosclerosis, v. 284, p. 59-65, 2019Tradução . . Disponível em: https://www.sciencedirect.com/science/article/pii/S0021915019300838?via%3Dihub. Acesso em: 04 out. 2023.
APA
Harada, P. H., Benseñor, I. M., Drager, L. F., Goulart, A. C., Mill, J. G., & Lotufo, P. A. (2019). Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil. Atherosclerosis, 284, 59-65. doi:10.1016/j.atherosclerosis.2019.02.005
NLM
Harada PH, Benseñor IM, Drager LF, Goulart AC, Mill JG, Lotufo PA. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil [Internet]. Atherosclerosis. 2019 ; 284 59-65.[citado 2023 out. 04 ] Available from: https://www.sciencedirect.com/science/article/pii/S0021915019300838?via%3Dihub
Vancouver
Harada PH, Benseñor IM, Drager LF, Goulart AC, Mill JG, Lotufo PA. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil [Internet]. Atherosclerosis. 2019 ; 284 59-65.[citado 2023 out. 04 ] Available from: https://www.sciencedirect.com/science/article/pii/S0021915019300838?via%3Dihub
Artigo de periodico
Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia (2019)
Reeskamp, Laurens F; Kastelein, John J. P; Moriarty, Patrick M; Duell, P. Barton; Catapano, Alberico L; Santos Filho, Raul Dias dos; Ballantyne, Christie M
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, OLIGONUCLEOTÍDEOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REESKAMP, Laurens F et al. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 280, p. 109-117, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.11.017. Acesso em: 04 out. 2023.
APA
Reeskamp, L. F., Kastelein, J. J. P., Moriarty, P. M., Duell, P. B., Catapano, A. L., Santos Filho, R. D. dos, & Ballantyne, C. M. (2019). Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, 280, 109-117. doi:10.1016/j.atherosclerosis.2018.11.017
NLM
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.11.017
Vancouver
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.11.017
Trabalho de evento-resumo periodico
Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle (2019)
Pinto, Paula Ramos ; Bianco, Vanessa Del; Bochi, Ana Paula Garcia; Ferreira, Guilherme da Silva; Trevisani, M. da Silva; Rodrigues, L. Gomes; Nakandakare, Edna Regina; Okamoto, Maristela Mitiko; Machado, Ubiratan Fabres ; Catanozi, Sergio ; Passarelli, Marisa
Source: Atherosclerosis. Conference titles: 87th European Atherosclerosis Society (EAS) Congress. Maastricht, Países Baixos. Unidades: FM, ICB
Subjects: FISIOLOGIA, RESISTÊNCIA À INSULINA, EXERCÍCIO FÍSICO, TREINAMENTO AERÓBIO, TREINAMENTO FÍSICO, SÓDIO, MÚSCULO ESQUELÉTICO, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Paula Ramos et al. Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle. Atherosclerosis. Amsterdan: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.06.273. Acesso em: 04 out. 2023. , 2019
APA
Pinto, P. R., Bianco, V. D., Bochi, A. P. G., Ferreira, G. da S., Trevisani, M. da S., Rodrigues, L. G., et al. (2019). Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle. Atherosclerosis. Amsterdan: Elsevier. doi:10.1016/j.atherosclerosis.2019.06.273
NLM
Pinto PR, Bianco VD, Bochi APG, Ferreira G da S, Trevisani M da S, Rodrigues LG, Nakandakare ER, Okamoto MM, Machado UF, Catanozi S, Passarelli M. Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle [Internet]. Atherosclerosis. 2019 ; 287 e94.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.06.273
Vancouver
Pinto PR, Bianco VD, Bochi APG, Ferreira G da S, Trevisani M da S, Rodrigues LG, Nakandakare ER, Okamoto MM, Machado UF, Catanozi S, Passarelli M. Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle [Internet]. Atherosclerosis. 2019 ; 287 e94.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.06.273
Artigo de periodico
In memoriam: Dr. Akira Yamamoto 1932-2019 (2019)
Matsuzawa, Yuji; Yamashita, Shizuya; Santos Filho, Raul Dias dos; Libby, Peter
Source: Atherosclerosis. Unidade: FM
Subjects: ESTATINAS, BIOGRAFIAS, MEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATSUZAWA, Yuji et al. In memoriam: Dr. Akira Yamamoto 1932-2019. Atherosclerosis, v. 283, p. 120-120, 2019Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/31641. Acesso em: 04 out. 2023.
APA
Matsuzawa, Y., Yamashita, S., Santos Filho, R. D. dos, & Libby, P. (2019). In memoriam: Dr. Akira Yamamoto 1932-2019. Atherosclerosis, 283, 120-120. doi:10.1016/j.atherosclerosis.2019.01.028
NLM
Matsuzawa Y, Yamashita S, Santos Filho RD dos, Libby P. In memoriam: Dr. Akira Yamamoto 1932-2019 [Internet]. Atherosclerosis. 2019 ; 283 120-120.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/31641
Vancouver
Matsuzawa Y, Yamashita S, Santos Filho RD dos, Libby P. In memoriam: Dr. Akira Yamamoto 1932-2019 [Internet]. Atherosclerosis. 2019 ; 283 120-120.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/31641
Artigo de periodico
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps (2019)
Santos Filho, Raul Dias dos; Valenti, Luca; Romeo, Stefano
Source: Atherosclerosis. Unidade: FM
Subjects: FÍGADO GORDUROSO, HEPATOPATIAS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos e VALENTI, Luca e ROMEO, Stefano. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis, v. 282, p. 110-120, 2019Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/31119. Acesso em: 04 out. 2023.
APA
Santos Filho, R. D. dos, Valenti, L., & Romeo, S. (2019). Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis, 282, 110-120. doi:10.1016/j.atherosclerosis.2019.01.029
NLM
Santos Filho RD dos, Valenti L, Romeo S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps [Internet]. Atherosclerosis. 2019 ; 282 110-120.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/31119
Vancouver
Santos Filho RD dos, Valenti L, Romeo S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps [Internet]. Atherosclerosis. 2019 ; 282 110-120.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/31119
Artigo de periodico-carta/editorial
Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH (2019)
Santos Filho, Raul Dias dos; Watts, Gerald F
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, ARTERIOSCLEROSE, CORONARIOPATIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos e WATTS, Gerald F. Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://observatorio.fm.usp.br/handle/OPI/31136. Acesso em: 04 out. 2023. , 2019
APA
Santos Filho, R. D. dos, & Watts, G. F. (2019). Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.atherosclerosis.2018.12.013
NLM
Santos Filho RD dos, Watts GF. Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH [Internet]. Atherosclerosis. 2019 ; 281 145-147.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/31136
Vancouver
Santos Filho RD dos, Watts GF. Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH [Internet]. Atherosclerosis. 2019 ; 281 145-147.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/31136
Artigo de periodico
Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia (2019)
Isla, Leopoldo Perez de; Ray, Kausik K.; Watts, Gerald F.; Santos Filho, Raul Dias dos ; Alonso, Rodrigo; Muniz-grijalvo, Ovidio; Diaz-diaz, Jose Luis; Badimon, Lina; Catapano, Alberico L; Mata, Pedro
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, AVALIAÇÃO DE RISCO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISLA, Leopoldo Perez de et al. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 286, p. 40-45, 2019Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/33058. Acesso em: 04 out. 2023.
APA
Isla, L. P. de, Ray, K. K., Watts, G. F., Santos Filho, R. D. dos, Alonso, R., Muniz-grijalvo, O., et al. (2019). Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis, 286, 40-45. doi:10.1016/j.atherosclerosis.2019.05.003
NLM
Isla LP de, Ray KK, Watts GF, Santos Filho RD dos, Alonso R, Muniz-grijalvo O, Diaz-diaz JL, Badimon L, Catapano AL, Mata P. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 286 40-45.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33058
Vancouver
Isla LP de, Ray KK, Watts GF, Santos Filho RD dos, Alonso R, Muniz-grijalvo O, Diaz-diaz JL, Badimon L, Catapano AL, Mata P. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 286 40-45.[citado 2023 out. 04 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33058
Artigo de periodico
Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users (2019)
Souza, Francis Ribeiro de; Santos, Marcelo Rodrigues dos; Porello, Rafael Armani; Fonseca, Guilherme Wesley Peixoto da; Sayegh, Ana Luiza Carrari; Lima, Thaís Pinheiro; Ferreira, Fabiana Dias; Oliveira, Tiago Franco de; Yonamine, Maurício ; Takayama, Liliam; Pereira, Rosa Maria Rodrigues; Negrão, Carlos Eduardo; Passarelli, Marisa; Rochitte, Carlos Eduardo; Alves, Maria Janieire de Nazaré Nunes
Source: Atherosclerosis. Unidades: FCF, FM, EEFE
Subjects: COLESTEROL, DOENÇAS CARDIOVASCULARES, ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Francis Ribeiro de et al. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users. Atherosclerosis, v. 283, p. 100-105, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2019.02.006. Acesso em: 04 out. 2023.
APA
Souza, F. R. de, Santos, M. R. dos, Porello, R. A., Fonseca, G. W. P. da, Sayegh, A. L. C., Lima, T. P., et al. (2019). Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users. Atherosclerosis, 283, 100-105. doi:10.1016/j.atherosclerosis.2019.02.006
NLM
Souza FR de, Santos MR dos, Porello RA, Fonseca GWP da, Sayegh ALC, Lima TP, Ferreira FD, Oliveira TF de, Yonamine M, Takayama L, Pereira RMR, Negrão CE, Passarelli M, Rochitte CE, Alves MJ de NN. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users [Internet]. Atherosclerosis. 2019 ; 283 100-105.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.02.006
Vancouver
Souza FR de, Santos MR dos, Porello RA, Fonseca GWP da, Sayegh ALC, Lima TP, Ferreira FD, Oliveira TF de, Yonamine M, Takayama L, Pereira RMR, Negrão CE, Passarelli M, Rochitte CE, Alves MJ de NN. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users [Internet]. Atherosclerosis. 2019 ; 283 100-105.[citado 2023 out. 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2019.02.006

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation